Philip Bonomi to Proto-Oncogene Proteins
This is a "connection" page, showing publications Philip Bonomi has written about Proto-Oncogene Proteins.
Connection Strength
0.172
-
An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC). Lung Cancer. 2017 02; 104:126-130.
Score: 0.142
-
Potential applications of apoptosis in modifying the biological behavior of therapeutically refractory cancers. Med Hypotheses. 1994 Oct; 43(4):207-13.
Score: 0.030